.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

The Evolution of Sequencing Strategies in Pancreatic Cancer

EP. 1: Multidisciplinary Care in Advanced Pancreatic Cancer

February 16th 2017

EP. 2: Current Practice With Molecular Testing in Pancreatic Cancer

February 16th 2017

EP. 3: Metastatic Pancreatic Cancer: Dosing Strategies in the Frontline Setting

February 16th 2017

EP. 4: Frontline Decisions in Metastatic Pancreatic Cancer

February 16th 2017

EP. 5: Liposomal Irinotecan in Advanced Pancreatic Cancer

February 16th 2017

EP. 6: Sequencing Decisions in Advanced Pancreatic Cancer

February 16th 2017

EP. 7: Advanced Pancreatic Cancer: Quality of Life Considerations

February 16th 2017

EP. 8: Neoadjuvant Therapy in Locally Advanced Pancreatic Cancer

February 16th 2017

EP. 9: Ongoing Neoadjuvant Clinical Trials in Pancreatic Cancer

February 16th 2017

EP. 10: Considerations in Locally Advanced Pancreatic Cancer

February 16th 2017

EP. 11: Adjuvant Therapy in Pancreatic Cancer

February 16th 2017

EP. 12: The Potential for Immunotherapy in Pancreatic Cancer

February 16th 2017

EP. 13: PEGPH20 in Advanced Pancreatic Cancer

February 16th 2017

EP. 14: Precision Medicine and the Future of Pancreatic Cancer

February 16th 2017